Skip to main content

Advertisement

Log in

Endotoxin opens the Toll gates to innate immunity

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Abstract

Mice that are resistant to lipopolysaccharide have mutations in a Toll–like receptor, implicating members of this family in bacterial endotoxin signaling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Thomas, L. The Lives of a Cell. Notes of a Biology Watcher. (The Viking Press, New York, 1974).

    Google Scholar 

  2. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085–2088 (1998).

    Article  CAS  Google Scholar 

  3. Kirschning, C.J., Wesche, H., Ayres, T.M. & Rothe, M. Human Toll–like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188, 2091–2097 (1998).

    Article  CAS  Google Scholar 

  4. Yang, R.B. et al. Toll–like receptor–2 mediates lipopolysaccharide–induced cellular signalling. Nature 17, 284– 288 (1998).

    Article  Google Scholar 

  5. Ulevitch, R.J. & Tobias, P.S. Receptor–dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13, 437–457 (1995).

    Article  CAS  Google Scholar 

  6. Medzhitov, R. & Janeway, C.A., Jr. Self–defense: The fruit fly style. Proc. Natl. Acad. Sci. USA 95, 429–430 (1998).

    Article  CAS  Google Scholar 

  7. Williams, M.J., Rodriguez, A., Kimbrell, D.A. & Eldon, E.D. The 18–wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J. 16, 6120–6130 (1997).

    Article  CAS  Google Scholar 

  8. Pugin, J. et al. CD14 is a pattern recognition receptor. Immunity 1, 509–516 (1994).

    Article  CAS  Google Scholar 

  9. Kuhns, D.B., Long Priel, D.A. & Gallin, J.I. Endotoxin and IL–1 hyporesponsiveness in a patient with recurrent bacterial infections. J. Immunol. 158, 3959–3964 (1997).

    CAS  PubMed  Google Scholar 

  10. Schimke, J., Mathison, J., Morgiewicz, J. & Ulevitch, R.J. Anti–CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc. Natl. Acad. Sci. USA 95, 13875–13880 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ulevitch, R. Endotoxin opens the Toll gates to innate immunity . Nat Med 5, 144–145 (1999). https://doi.org/10.1038/5504

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/5504

  • Springer Nature America, Inc.

This article is cited by

Navigation